超过5%股东持股披露
AN2 Therapeutics(ANTX)07-03 20:05
$AN2 Therapeutics(ANTX)$ SC 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001214659-24-011905 Act: 34 Size: 68 KB 网页链接
简介:AN2 Therapeutics, Inc.于2017年2月在特拉华州注册成立。他们是一家临床阶段的生物制药公司,开发治疗罕见、慢性和严重传染病的治疗方法。他们的核心技术方法基于将硼化学用于他们的药物研发计划。他们正在开发用于治疗NTM肺病的口服epetraborole,这是一种罕见的慢性进行性传染病,由称为分枝杆菌的细菌引起,可导致不可逆的肺损伤并可能致命。
今开:2.65 | 昨收:2.64 |
最高:2.65 | 最低:2.6004 |
涨停价: | 跌停价: |
总市值:77567436 |
AN2 Therapeutics(ANTX)07-03 20:05
$AN2 Therapeutics(ANTX)$ SC 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001214659-24-011905 Act: 34 Size: 68 KB 网页链接
AN2 Therapeutics(ANTX)06-22 06:25
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076406 Size: 17 KB 网页链接
AN2 Therapeutics(ANTX)05-15 04:15
$AN2 Therapeutics(ANTX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-059556 Act: 34 Size: 6 MB 网页链接
AN2 Therapeutics(ANTX)06-25 04:15
$AN2 Therapeutics(ANTX)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001193125-24-166938 Act: 34 Size: 199 KB 网页链接
AN2 Therapeutics(ANTX)06-22 06:25
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076410 Size: 17 KB 网页链接
AN2 Therapeutics(ANTX)06-22 06:25
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076404 Size: 18 KB 网页链接
AN2 Therapeutics(ANTX)05-15 04:05
$AN2 Therapeutics(ANTX)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-059488 Act: 34 Size: 1 MB 网页链接
AN2 Therapeutics(ANTX)06-22 06:05
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076369 Size: 17 KB 网页链接
AN2 Therapeutics(ANTX)06-22 06:05
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076374 Size: 17 KB 网页链接
AN2 Therapeutics(ANTX)06-22 06:15
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076399 Size: 18 KB 网页链接
牛唐2022-08-15 21:49
$AN2 Therapeutics(ANTX)$ 又一个50%+的收益。$美团-W(03690)$ $阿里巴巴(BABA)$查看全文
同写意2022-04-19 21:22
编译丨Daisy
编辑丨于靖
2022年第一季度是三年来新股发行最慢的一个季度,迫使初创的制药企业在更艰难的融资环境中另寻出路。
想要上市的生物科技公司正面临着一个与一年前完全不同的世界。
行业股价暴跌,过去两年创下纪录的IPO步伐也因此放缓。初创的制药企业再也无法获得2021年...查看全文
chuminhua2022-03-28 16:26
3月25日,AN2 Therapeutics 扩大 IPO 规模,募集 6900 万美元用于从辉瑞(Pfizer)的 Anacor Pharmaceuticals 获得的抗生素epetraborole的关键试验。
epetraborole 是一种细菌亮氨酰-tRNA 合成酶的小分子抑制剂,Anacor 和葛兰素史克在十多年前进行了临床试验。葛兰素史克在 2 期试验中发现一...查看全文
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-083200 Size: 17 KB 网页链接
$AN2 Therapeutics(ANTX)$ SC 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001214659-24-011905 Act: 34 Size: 68 KB 网页链接
$AN2 Therapeutics(ANTX)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001193125-24-166938 Act: 34 Size: 199 KB 网页链接
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076404 Size: 18 KB 网页链接
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076406 Size: 17 KB 网页链接
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076410 Size: 17 KB 网页链接
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076408 Size: 17 KB 网页链接
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076399 Size: 18 KB 网页链接
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076369 Size: 17 KB 网页链接
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076374 Size: 17 KB 网页链接